|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
IVAX Research LLC |
| Information provided by: | IVAX Research LLC |
| ClinicalTrials.gov Identifier: | NCT00054964 |
Purpose
This study is designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.
| Condition | Intervention | Phase |
|
Asthma |
Drug: Albuterol |
Phase II |
| MedlinePlus related topics: | Asthma |
| ChemIDplus related topics: | Albuterol sulfate Albuterol Levalbuterol hydrochloride Levalbuterol tartrate |
| Study Type: | Interventional |
| Study Design: | Treatment |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | IXR-202-4-167 |
| First Received: | February 14, 2003 |
| Last Updated: | May 6, 2008 |
| ClinicalTrials.gov Identifier: | NCT00054964 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|